Lombard Odier Asset Management (Europe) LTD Cytokinetics Inc Transaction History
Lombard Odier Asset Management (Europe) LTD
- $1.01 Billion
- Q1 2025
A detailed history of Lombard Odier Asset Management (Europe) LTD transactions in Cytokinetics Inc stock. As of the latest transaction made, Lombard Odier Asset Management (Europe) LTD holds 46,200 shares of CYTK stock, worth $1.59 Million. This represents 0.18% of its overall portfolio holdings.
Number of Shares
46,200Holding current value
$1.59 Million% of portfolio
0.18%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding CYTK
# of Institutions
385Shares Held
127MCall Options Held
3.68MPut Options Held
835K-
Black Rock Inc. New York, NY14.7MShares$503 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA12MShares$411 Million0.01% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD9.96MShares$342 Million0.26% of portfolio
-
Wellington Management Group LLP Boston, MA7.99MShares$274 Million0.06% of portfolio
-
State Street Corp Boston, MA6.09MShares$209 Million0.01% of portfolio
About CYTOKINETICS INC
- Ticker CYTK
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 94,144,096
- Market Cap $3.23B
- Description
- Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...